Navigation Links
Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference
Date:10/18/2007

DALLAS, Oct. 18 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) announced today that its collaborators will be presenting clinical and preclinical data on its lead anticancer compound, ProLindac(TM), at the joint symposium of the American Association for Cancer Research (AACR), National Cancer Institute (NCI) and European Organization for Research and Treatment of Cancer (EORTC) entitled "International Conference Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications" taking place October 22-26, 2007 at the Moscone Convention Center West in San Francisco, CA.

An update on Access' ongoing ProLindac Phase 2 clinical study will be presented during Poster Session A, "Clinical Trials" in Abstract #A145 entitled "AP5346, a pH-dependent polymer-vectorized DACH, is safe at pharmacodynamically active doses: Results from an ongoing phase II trial in borderline potentially platinum-sensitive ovarian cancer (OC) patients" on Tuesday, October 23, 2007 from 12:30 p.m. PDT.

New ProLindac preclinical data will appear in two posters presented during Poster Session C, Novel Drug Delivery Systems, on Thursday, October 25, 2007 from 12:30 p.m. PDT:

Abstract #C105 : "Molecular and cellular effects of AP5346, a novel DACH- platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines."

Abstract #C110: "Antiproliferative activity of AP5346, a novel DACH- platinum compound, alone and in combination with other cytotoxics, in human colon and ovarian cancer cells."

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion.

About
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015  Merrimack Pharmaceuticals, Inc. (Nasdaq: ... liposome injection), also known as ,nal-IRI, in a Phase ... Francisco for high-grade glioma. Data were presented at the ... in Chicago, IL. Results from ... in patients with high-grade glioma when given intravenously.  ...
(Date:6/1/2015)... , June 1, 2015 ... body weight over large area and improve the quality ... pressure ulcer. These devices play a significant role in ... help reduce the need to turn or rotate an ... devices include mattress, mattresses overlay, and specialty beds. These ...
(Date:6/1/2015)... -- The Middle Eastern MRI systems market is fast growing. ... because of its higher sensitivity and use of non-ionizing radiations. ... available systems of MRI, open and closed. Open MRI systems ... do not enclose the patient in a tunnel. This prevents ... that one in every 6 patients suffers from claustrophobia hence ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2
... DES MOINES, Iowa, Oct. 16 Protocol ... and announced a partnership,with Hallmark Insights to ... to users of the ConXus health improvement ... and fulfillment services,for reward points earned by ...
... K. Khouri, M.D. a noted Plastic,and Reconstructive Surgeon, ... a,clinical trial performing a minimally invasive breast reconstruction,technique ... grafts primarily on women who have had a ... Typically, breast reconstruction procedures involve major, "open",surgery that ...
Cached Medicine Technology:PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study 2
(Date:6/1/2015)... Chicago (PRWEB) June 01, 2015 ... opportunity for anyone interested in participating in the ... Marine Corps Marathons to secure guaranteed entry by ... MDA Team Momentum. However, space is limited. , ... customized for all levels and abilities, and a ...
(Date:6/1/2015)... June 01, 2015 Sharenote, a leading ... for the Healthcare Industry this week in Louisiana. The ... in four days to provide potential providers with the ... profitability, and monitor risk within their network. , ... and is being used by more than 250 practices. ...
(Date:6/1/2015)... More than 22 million children may miss out on milk’s ... they lose access to free or reduced-price meal programs. June ... companies are on a mission to bring more nutritious milk ... , In many cases, food insecure children depend on ... bulk of their daily nutrition. Although the National School Lunch ...
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity ... using more granular data to create better customer oriented ... voices in Josep Celaya Gonzalez, CIO at MAPFRE, and ... an automotive insurer, MAPFRE are well versed in capturing ... to the driver. Award winning start-up ParkTAG offer an ...
(Date:6/1/2015)... June 01, 2015 The session, entitled ... Artur Seidel, vice president of Elektrobit Automotive Americas, ... John Ellis; it will be moderated by Andy Gryc ... growing importance and complexity of in-vehicle software in connected ... of security and how the wider ecosystem can fit ...
Breaking Medicine News(10 mins):Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3
... innovative products and technology to the ophthalmic lens market, today announced its unaudited financial results for the fourth quarter and year ended December 31, 2009 . , ... , ... ... ...
... ... ... International (TNI) announced that Tahitian Noni® Bioactive Beverages™ contain iridoids —a bioactive compound ... over 50 years and now 12 unique iridoids have been identified in the noni ...
... ... $25 or more for all hand and body lotions as well as facial serums. ... Southfield, Mich. (PRWEB) March 11, ... with an emphasis on the key ingredient African Shea butter. The products are highly sought ...
... ... Disadvantaged Elderly/Disabled Adults and Co-Sponsors Annual Capital Area Dental Foundation Gala. , ... (PRWEB) March 11, 2010 -- ... of Austin Smiles has jumped in with both feet and has begun participating in ...
... ... Treating Back Pain for Over 25 Years , ... Pittsburgh, PA (PRWEB) March 10, 2010 -- Allegheny Medical ... quality and most cost effective health care since 1984. Today, Allegheny Medical remains committed ...
... ... balance, the human body is a self-healing biochemical organism. Unfortunately, modern ... of balance., NutriLuxe Solaris tests the body,s biochemical and electrical balance ... level and electrical conductivity, as well as other health factors. Once ...
Cached Medicine News:Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 2Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 3Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 4Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 5Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 6Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 7Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 8Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 9Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 10Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 11Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 12Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 13Health News:Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results 14Health News:12 Unique Iridoids Have Been Found in Noni Fruit 2Health News:Free Shipping On Hand and Body Lotions Made with African Shea Butter 2Health News:Austin Cosmetic Dentist Dr. Michael McCarty Co-Sponsors Capital Area Dental Foundation Gala 2Health News:Austin Cosmetic Dentist Dr. Michael McCarty Co-Sponsors Capital Area Dental Foundation Gala 3Health News:Allegheny Medical Integrated Health Services Offers Complimentary Consultations for Sufferers of Chronic Back Pain 2Health News:Allegheny Medical Integrated Health Services Offers Complimentary Consultations for Sufferers of Chronic Back Pain 3Health News:NutriLuxe Offers Personal, At-Home Body Biochemical Balance Test 2Health News:NutriLuxe Offers Personal, At-Home Body Biochemical Balance Test 3
... BioZip Suture Anchor is a unique double loaded ... is made from Poly-L Lactic Acid (PLLA) and ... are attached to the suture ends for open ... repairs. The trocar tip inserter allows insertion with ...
... LactoSorb copolymer is an absorbable ... L-Lactic acid and 18% glycolic acid. ... such as 100% poly-L-lactic acid (PLLA) ... copolymer is substantially amorphous (without crystallinity), ...
... is an absorbable co-polymer synthesized from ... 18% glycolic acid. Unlike the homopolymers ... poly-L-lactic acid (PLLA) or 100% poly-glycolic ... amorphous (without crystallinity), meaning that its ...
... The USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor ... to attach soft tissue to bone using sutures. ... prepared hole in the bone, and is used ... are made of a resorbable copolymer, derived from ...
Medicine Products: